Arena Pharmaceuticals, Inc. (ARNA)
Price:
99.99 USD
( - 0 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Regeneron Pharmaceuticals, Inc.
VALUE SCORE:
6
2nd position
Genmab A/S
VALUE SCORE:
11
The best
Agios Pharmaceuticals, Inc.
VALUE SCORE:
12
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
DESCRIPTION
Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on providing novel medicines with pharmacology and pharmacokinetics to patients worldwide. The company's investigational clinical programs include Etrasimod (APD334) that is in Phase III clinical trial for ulcerative colitis, Phase IIb/III clinical trial for Crohn's disease, Phase II clinical trial for alopecia areata, Phase III clinical trial for atopic dermatitis, and Phase IIb clinical trial for eosinophilic esophagitis; Olorinab (APD371), which is in Phase IIb clinical trial for the treatment of abdominal pain associated with irritable bowel syndrome; APD418 that is in Phase II clinical trial for acute heart failure; and Temanogrel for coronary microvascular obstruction that is in Phase II clinical trial. It also develops ralinepag (APD811), which is in Phase III clinical trial for pulmonary arterial hypertension. The company has collaboration agreements with United Therapeutics Corporation; Everest Medicines Limited; Eisai Co., Ltd. and Eisai Inc.; Boehringer Ingelheim International GmbH; Beacon Discovery, Inc.; and Aristea Therapeutics, Inc. Arena Pharmaceuticals, Inc. was incorporated in 1997 and is based in Park City, Utah. As of March 11, 2022, Arena Pharmaceuticals, Inc. operates as a subsidiary of Pfizer Inc.
NEWS
Pfizer closes $6.7 billion acquisition of Arena Pharmaceuticals
marketwatch.com
2022-03-11 11:04:21Shares of Pfizer Inc. PFE, +2.32% were up 2.0% in trading on Friday after the company said it closed its $6.7 billion acquisition of Arena Pharmaceuticals Inc. Arena is developing treatments for immuno-inflammatory diseases like ulcerative colitis and atopic dermatitis. It has said it expects to share data from a Phase 3 clinical trial testing one of those experimental therapies, etrasimod, in ulcerative colitis patients during the first quarter of his year.
Pfizer Completes Acquisition of Arena Pharmaceuticals
businesswire.com
2022-03-11 08:34:00NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today the completion of its acquisition of Arena Pharmaceuticals, a clinical stage company developing innovative potential therapies for the treatment of several immuno-inflammatory diseases. Arena Pharmaceuticals brings to Pfizer a portfolio of diverse and promising development-stage therapeutic candidates in gastroenterology, dermatology, and cardiology, including etrasimod, an oral, selective sphingosine 1-phosphate (S1P) receptor
7 Biotech Stocks With Key Catalysts in March
investorplace.com
2022-03-09 06:24:06These seven stocks have some key catalysts lined up for March with the potential to move their price actions in big ways. The post 7 Biotech Stocks With Key Catalysts in March appeared first on InvestorPlace.
11 Marijuana Stocks on Fire to Close February
schaeffersresearch.com
2022-02-28 15:05:13Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks, and look at how the cannabis industry is evolving as we make our way through 2022.
Arena (ARNA) Q4 Loss Wider Than Expected, Etrasimod in Focus
zacks.com
2022-02-24 19:15:57Arena Pharmaceuticals (ARNA) misses on Q4 bottom line. Top-line data from several phase III studies on etrasimod are slated for release in 2022.
Top 3 weed stocks to put on your watch list this year
invezz.com
2022-02-17 19:30:00The marijuana industry has seen sharp growth year on year.
Pharma Giants Go After $10 Billion Market With RSV Drugs
gurufocus.com
2022-01-18 16:33:53GlaxoSmithKline PLC ( GSK , Financial), Pfizer Inc. ( PFE , Financial) and Johnson & Johnson ( JNJ , Financial) should all know about mid-year if the shots they're developing for a common and potentially fatal virus is effective. No, the it isn't for Covid-19, but for respiratory syncytial virus, which causes an estimated 177,000 hospitalizations among older adults each year and 58,000 in children under five.
Cannabis Watch: Pfizer's Arena Pharma deal may lead drug company to a cannabis-based treatment
marketwatch.com
2021-12-23 12:01:00Pfizer Inc.'s presentation of its pending $6.7 billion acquisition of clinical-stage drug company Arena Pharmaceuticals Inc. contained no mention of cannabis.
Should You Buy Arena Pharmaceuticals, Inc. (ARNA) After Golden Cross?
zacks.com
2021-12-22 11:28:14Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
Abivax: Potentially The Next Arena Pharmaceuticals, Most Ideal Big Pharma M&A Target In 2022
seekingalpha.com
2021-12-15 22:13:38Arena Pharmaceuticals got acquired by Pfizer for US$ 6.7 Bn (~100% valuation) on December 12th. As a result, the market for late-stage oral IBD candidates that big pharma can acquire is thinning.
Pfizer (PFE) to Buy Arena, Boost Immuno-Inflammatory Pipeline
zacks.com
2021-12-14 10:44:30Pfizer (PFE) signs an agreement to acquire Arena Pharmaceuticals for $6.7 billion in cash. Stock rises.
Does PFE, ARNA Deal Signal Robust Pharma M&A Activity in 2022?
zacks.com
2021-12-14 10:44:27The Pfizer (PFE)-Arena (ARNA) deal raises hopes that M&A activity will pick up significantly in 2022. as big drugmakers are sitting on huge piles of cash.
Pfizer's acquisition of Arena "shows big pharma's interest in cannabinoid medicines"
proactiveinvestors.co.uk
2021-12-14 07:28:43Pfizer Inc's (NYSE:PFE) agreed acquisition of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) for almost double the closing price of the stock in the previous trading sessions, is just the latest case of big pharma's confidence to get into cannabinoid-based research, said the manager of an ETF focused on the sector. Nawan Butt, portfolio manager of The Medical Cannabis and Wellness UCITS ETC (CBDX) says it is also another example of the huge growth potential for the medical cannabis sector and how it is becoming more mainstream.
Why Arena Pharmaceuticals Stock Skyrocketed 80% Today
fool.com
2021-12-13 17:44:04A healthcare titan wants to acquire the drug developer for nearly $7 billion.
SHAREHOLDER ALERT: WeissLaw LLP Investigates Arena Pharmaceuticals, Inc.
prnewswire.com
2021-12-13 17:15:00NEW YORK, Dec. 13, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Arena Pharmaceuticals, Inc. ("Arena" or the "Company") (NASDAQ: ARNA), in connection with the proposed acquisition of the Company by Pfizer Inc. ("Pfizer") (NYSE: PFE). Under the terms of the merger agreement, the Company's shareholders will receive $100.00 per share in cash for each share of Arena common stock that they hold.
Arena Pharmaceuticals up 90% after acquisition announcement
invezz.com
2021-12-13 15:21:49Pfizer Inc (NYSE: PFE) executed a definitive agreement with Arena Pharmaceuticals (Nasdaq: ARNA), under which Pfizer Inc will acquire Arena Pharmaceutical for a total equity value of around $6.7 billion. Arena went up 90% after this announcement.
No data to display
Pfizer closes $6.7 billion acquisition of Arena Pharmaceuticals
marketwatch.com
2022-03-11 11:04:21Shares of Pfizer Inc. PFE, +2.32% were up 2.0% in trading on Friday after the company said it closed its $6.7 billion acquisition of Arena Pharmaceuticals Inc. Arena is developing treatments for immuno-inflammatory diseases like ulcerative colitis and atopic dermatitis. It has said it expects to share data from a Phase 3 clinical trial testing one of those experimental therapies, etrasimod, in ulcerative colitis patients during the first quarter of his year.
Pfizer Completes Acquisition of Arena Pharmaceuticals
businesswire.com
2022-03-11 08:34:00NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today the completion of its acquisition of Arena Pharmaceuticals, a clinical stage company developing innovative potential therapies for the treatment of several immuno-inflammatory diseases. Arena Pharmaceuticals brings to Pfizer a portfolio of diverse and promising development-stage therapeutic candidates in gastroenterology, dermatology, and cardiology, including etrasimod, an oral, selective sphingosine 1-phosphate (S1P) receptor
7 Biotech Stocks With Key Catalysts in March
investorplace.com
2022-03-09 06:24:06These seven stocks have some key catalysts lined up for March with the potential to move their price actions in big ways. The post 7 Biotech Stocks With Key Catalysts in March appeared first on InvestorPlace.
11 Marijuana Stocks on Fire to Close February
schaeffersresearch.com
2022-02-28 15:05:13Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks, and look at how the cannabis industry is evolving as we make our way through 2022.
Arena (ARNA) Q4 Loss Wider Than Expected, Etrasimod in Focus
zacks.com
2022-02-24 19:15:57Arena Pharmaceuticals (ARNA) misses on Q4 bottom line. Top-line data from several phase III studies on etrasimod are slated for release in 2022.
Top 3 weed stocks to put on your watch list this year
invezz.com
2022-02-17 19:30:00The marijuana industry has seen sharp growth year on year.
Pharma Giants Go After $10 Billion Market With RSV Drugs
gurufocus.com
2022-01-18 16:33:53GlaxoSmithKline PLC ( GSK , Financial), Pfizer Inc. ( PFE , Financial) and Johnson & Johnson ( JNJ , Financial) should all know about mid-year if the shots they're developing for a common and potentially fatal virus is effective. No, the it isn't for Covid-19, but for respiratory syncytial virus, which causes an estimated 177,000 hospitalizations among older adults each year and 58,000 in children under five.
Cannabis Watch: Pfizer's Arena Pharma deal may lead drug company to a cannabis-based treatment
marketwatch.com
2021-12-23 12:01:00Pfizer Inc.'s presentation of its pending $6.7 billion acquisition of clinical-stage drug company Arena Pharmaceuticals Inc. contained no mention of cannabis.
Should You Buy Arena Pharmaceuticals, Inc. (ARNA) After Golden Cross?
zacks.com
2021-12-22 11:28:14Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
Abivax: Potentially The Next Arena Pharmaceuticals, Most Ideal Big Pharma M&A Target In 2022
seekingalpha.com
2021-12-15 22:13:38Arena Pharmaceuticals got acquired by Pfizer for US$ 6.7 Bn (~100% valuation) on December 12th. As a result, the market for late-stage oral IBD candidates that big pharma can acquire is thinning.
Pfizer (PFE) to Buy Arena, Boost Immuno-Inflammatory Pipeline
zacks.com
2021-12-14 10:44:30Pfizer (PFE) signs an agreement to acquire Arena Pharmaceuticals for $6.7 billion in cash. Stock rises.
Does PFE, ARNA Deal Signal Robust Pharma M&A Activity in 2022?
zacks.com
2021-12-14 10:44:27The Pfizer (PFE)-Arena (ARNA) deal raises hopes that M&A activity will pick up significantly in 2022. as big drugmakers are sitting on huge piles of cash.
Pfizer's acquisition of Arena "shows big pharma's interest in cannabinoid medicines"
proactiveinvestors.co.uk
2021-12-14 07:28:43Pfizer Inc's (NYSE:PFE) agreed acquisition of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) for almost double the closing price of the stock in the previous trading sessions, is just the latest case of big pharma's confidence to get into cannabinoid-based research, said the manager of an ETF focused on the sector. Nawan Butt, portfolio manager of The Medical Cannabis and Wellness UCITS ETC (CBDX) says it is also another example of the huge growth potential for the medical cannabis sector and how it is becoming more mainstream.
Why Arena Pharmaceuticals Stock Skyrocketed 80% Today
fool.com
2021-12-13 17:44:04A healthcare titan wants to acquire the drug developer for nearly $7 billion.
SHAREHOLDER ALERT: WeissLaw LLP Investigates Arena Pharmaceuticals, Inc.
prnewswire.com
2021-12-13 17:15:00NEW YORK, Dec. 13, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Arena Pharmaceuticals, Inc. ("Arena" or the "Company") (NASDAQ: ARNA), in connection with the proposed acquisition of the Company by Pfizer Inc. ("Pfizer") (NYSE: PFE). Under the terms of the merger agreement, the Company's shareholders will receive $100.00 per share in cash for each share of Arena common stock that they hold.
Arena Pharmaceuticals up 90% after acquisition announcement
invezz.com
2021-12-13 15:21:49Pfizer Inc (NYSE: PFE) executed a definitive agreement with Arena Pharmaceuticals (Nasdaq: ARNA), under which Pfizer Inc will acquire Arena Pharmaceutical for a total equity value of around $6.7 billion. Arena went up 90% after this announcement.